CT scan for lung infection caused by Mucorales fungus
Part of Infections clinical trials.
This trial looks at CT scan results to see if they can help predict how someone with a serious lung infection caused by Mucorales fungus will do. It asks whether certain features on CT scans can give clues about recovery and future health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have been treated at Strasbourg University Hospital between 2009 and June 2025
- You must have a confirmed lung infection with Mucorales fungus (called pulmonary mucormycosis)
- You must have had at least one CT scan of your chest as part of your care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for specific lab “biomarkers” in people with mucormycosis, a serious fungal infection. It compares results with people who have higher infection risk but no active infection, to help doctors diagnose and track this illness more accurately.
This study looks at whether pictures from a lung CT and a bronchoscopy can help doctors quickly find the germ causing severe pneumonia. If you participate, your existing medical records will be reviewed to see if combining these imaging tests with lab tests speeds up diagnosis and improves treatment.
This trial tests a new PET scan that uses a special marker to see if you have an invasive fungal infection. It may help doctors better diagnose and treat these infections.
This trial checks whether a PET-CT scan using a small amount of tracer (FDG) can help doctors better identify invasive fungal infections inside the body. It may be useful for guiding diagnosis when standard information is unclear.
This trial is testing a new way to look at CT scans (called spectral imaging) to see if it can better detect lung cancer in people who are suspected of having it. If you are being referred for lung cancer testing, this study may help doctors get clearer information from your scans.
This trial tests how well a CT scan and lung function tests can measure interstitial lung disease (ILD), which is long-term scarring or inflammation in the lungs. It may help doctors use these images and tests more accurately to track ILD.
Hear when a new Pulmonary Mucormycosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.